Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy

Por Li, H, Peng, K-W, Dingli, D, Kratzke, R A, Russell, S J
Publicado em 2010

Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors

Por Escobar-Zarate, D, Liu, Y-P, Suksanpaisan, L, Russell, SJ, Peng, K-W
Publicado no Cancer Gene Ther (2013)

Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses

Por Peng, K-W, Myers, R, Greenslade, A, Mader, E, Greiner, S, Federspiel, MJ, Dispenzieri, A, Russell, SJ
Publicado em 2012

Dynamics of multiple myeloma tumor therapy with a recombinant measles virus

Por Dingli, D, Offord, C, Myers, R, Peng, K-W, Carr, TW, Josic, K, Russell, SJ, Bajzer, Z
Publicado em 2009

Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without Cyclophosphamide

Por Myers, RM, Greiner, SM, Harvey, ME, Griesmann, G, Kuffel, MJ, Buhrow, SA, Reid, JM, Federspiel, M, Ames, MM, Dingli, D, Schweikart, K, Welch, A, Dispenzieri, A, Peng, K-W, Russell, SJ
Publicado em 2007